CAS号 |
产品英文名称 |
分子式 |
|
HIV-1 MN ENV-204 |
C61 H104 N16 O24 |
|
HIV-1 MN ENV-205 |
C64 H110 N18 O24 |
|
HIV-1 MN NO 2047 |
C90 H158 N30 O29 |
|
HIV-1 MN NO 2048 |
C99 H174 N36 O26 |
|
HIV-1 MN ENV-206 |
C70 H122 N22 O24 |
|
HIV-1 MN ENV-207 |
C68 H121 N25 O22 |
|
HIV-1 MN ENV-208 |
C76 H134 N24 O19 |
|
HIV-1 MN ENV-209 |
C76 H135 N27 O18 |
|
HIV-1 MN ENV-210 |
C75 H133 N27 O18 |
|
HIV-1 MN ENV-211 |
C78 H137 N27 O20 |
|
HIV-1 MN ENV-212 |
C61 H112 N22 O17 |
|
HXB2 GAG NO 2/AA5-19 |
C73 H118 N20 O24 |
|
HXB2 GAG NO 3/AA9-23 |
C79 H130 N26 O23 |
|
HXB2 GAG NO 4 |
C83 H142 N28 O20 |
|
HXB2 GAG NO 5 |
C83 H148 N26 O19 |
|
HXB2 GAG NO 7/AA25-39 |
C87 H144 N26 O18 |
|
HXB2 GAG NO 8 |
C89 H142 N26 O22 |
|
HXB2 GAG NO 9/AA33-47 |
C83 H127 N25 O22 |
|
HXB2 GAG NO 10 |
C74 H122 N22 O22 |
|
HXB2 GAG NO 12/AA45-59 |
C64 H108 N20 O24 S |
|
HXB2 GAG NO 13 |
C66 H114 N20 O24 S |
|
HEXYL(NAPHTHALEN-1-YLMETHYL)AMINE |
C17 H23 N |
|
H1-S6A,F8A C-MYC INHIBITOR |
C72 H121 N23 O21 |
|
HIV-1 MN ENV-16 |
C72 H108 N20 O24 S |
|
HIV-1 MN ENV-17 |
C71 H105 N21 O23 S |
|
HIV-1 MN ENV-18 |
C65 H104 N18 O25 S |
|
HIV-1 MN ENV-19 |
C70 H112 N18 O26 S |
|
HIV-1 MN ENV-20 |
C71 H113 N19 O29 |
|
HIV-1 MN ENV-21 |
C82 H122 N20 O27 S |
|
HIV-1 MN ENV-22 |
C81 H124 N22 O24 S2 |
|
HIV-1 MN ENV-23 |
C81 H122 N22 O26 S3 |
|
HIV-1 MN ENV-24 |
C80 H123 N23 O26 S3 |
|
HIV-1 MN ENV-25 |
C80 H123 N21 O26 S2 |
|
HIV-1 MN ENV-26 |
C80 H122 N20 O28 S |
|
HIV-1 MN ENV-30 |
C69 H121 N17 O20 S3 |
|
HIV-1 MN ENV-31 |
C70 H122 N20 O23 S2 |
|
HIV-1 MN ENV-32 |
C65 H113 N21 O26 S2 |
|
HIV-1 MN ENV-33 |
C62 H105 N23 O29 S |
|
HIV-1 MN ENV-34 |
C62 H105 N25 O28 |
|
HXB2 GAG NO 79/AA313-327 |
C77 H125 N21 O24 S |
|
HXB2 GAG NO 80 |
C69 H117 N19 O25 S2 |
|
HXB2 GAG NO 81 |
C73 H128 N20 O22 S |
|
HXB2 GAG NO 82/AA325-339 |
C67 H115 N19 O21 S |
|
HXB2 GAG NO 83/AA329-343 |
C67 H119 N17 O20 S |
|
HXB2 GAG NO 84 |
C70 H122 N16 O21 S2 |
|
HXB2 GAG NO 85/AA337-351 |
C64 H108 N16 O23 S3 |
|
HXB2 GAG NO 86/AA341-355 |
C59 H100 N16 O23 S3 |
|
HXB2 GAG NO 87 |
C60 H99 N19 O20 S3 |
|
HXB2 GAG NO 88/AA349-363 |
C61 H104 N22 O17 S |
|
HXB2 GAG NO 89/AA353-367 |
C63 H107 N21 O18 S |
|
HXB2 GAG NO 90 |
C67 H116 N22 O21 S |
|
HXB2 GAG NO 91/AA361-375 |
C64 H112 N20 O24 S |
|
HXB2 GAG NO 92/AA365-379 |
C65 H112 N18 O25 S3 |
|
HXB2 GAG NO 93 |
C70 H116 N22 O23 S2 |
|
HXB2 GAG NO 94 |
C73 H124 N28 O22 S2 |
|
HXB2 GAG NO 95/AA377-391 |
C80 H140 N30 O20 S2 |
|
H-GLU-ARG-VAL-THR-LEU-THR-ARG-CYS-PHE-TYR-LEU-PHE-PRO-GLY-HIS-OH |
C85 H127 N23 O21 S |
|
H-ALA-ASP-LYS-VAL-LEU-LYS-GLU-LYS-ARG-LYS-LEU-PHE-ILE-ARG-SER-MET-GLY-GLU-OH |
C95 H166 N28 O26 S |
|
HA EPITOPE/FUSION TAG, 9AA HEME AGG EOITOPE |
|
|
HALOPERIDOL, BSA |
|
|
HALOPERIDOL, TG CONJUGATE |
|
|
HEPATITIS B 'E' ANTIGEN, E COLI |
|
|
HEXOKINASE I, HUMAN, 20 AA NEAR NT |
|
|
HEXOKINASE II, HUMAN, 16 AA NEAR CT |
|
|
HEXOKINASE III, HUMAN, 20 AA NEAR CT |
|
|
HEXOKINASE III, RAT, 19 AA NEAR CT |
|
|
H1R, HUMAN, 19 AA NEAR INTERNAL DOMAIN |
|
|
H1R, RAT, 14AA NEAR CT |
|
124006-38-8
|
HEXACHLOROMETHYL-HEXAMETHOXYCALIX-[6]ARENE |
C54 H54 Cl6 O6 |
238074-03-8
|
HYPERFORIN DICYCLOHEXYLAMMONIUM SALT |
C35 H52 O4 . C12 H23 N |
|
HYPOCRETIN-A, MOUSE, 17AA NEAR NT |
|
|
HYPOCRETIN-1 RECEPTOR, HUMAN |
|
|
HYPOCRETIN-2 RECEPTOR, HUMAN, 19AA NEAR RAT CT/19AA NEAR HUMAN NT |
|
|
HYPOCRETIN-2 RECEPTOR, RAT, 19AA NEAR RAT CT/19AA NEAR HUMAN NT |
|
|
HIV-1 CONSENSUS B VIF-1 |
C88 H136 N26 O23 S2 |
|
HIV-1 CONSENSUS B VIF-2 |
C91 H146 N28 O20 S2 |
|
HIV-1 CONSENSUS B VIF-3 |
C89 H144 N28 O21 S |
|
HIV-1 CONSENSUS B VIF-4 |
C85 H145 N29 O20 S |
|
HIV-1 CONSENSUS B VIF-5 |
C91 H146 N28 O19 S |
|
HIV-1 CONSENSUS B VIF-6 |
C83 H129 N23 O19 S |